Yuanxin Technology and Pfizer Elevate Strategic Partnership at CIIE to Advance Tiered Pharmacy Management and Hospital-Pharmacy Integration

On November 6, 2025, during the grand hosting of the 8th China International Import Expo,The SecondPfizer DTP Strategic Development ForumSuccessfully convened. Yuanxin Technology Group, as a long-term ecological partner of Pfizer China and a pioneer in the field of comprehensive patient services outside hospitals, was invited to participate in this forum.Mr. He Tao, Chairman and CEO of Yuanxin Technology Group, attended the roundtable discussion, sharing insights on "Value Co-creation in the New Ecosystem for Innovative Drug Commercialization," and announced a new upgrade in strategic cooperation with Pfizer.

Against the backdrop of China's ongoing deepening reform of its medical system and the coordinated advancement of multiple policies,DTP pharmacies have evolved from traditional drug deliveryRole, evolving into a professional platform connecting patients, pharmaceuticals, and medical services.StructureBuildThe three-dimensional collaborative system of "hierarchical management to solidify the foundation, hospital-store linkage to close the loop, and ecological co-construction to unleash value" is a key path to meeting patients' diverse needs and achieving high-quality development in the industry.。

As a world-leading innovative biopharmaceutical company, Pfizer has always been committed to providing therapeutic solutions through science and global resources to prolong people's lives and significantly improve their quality of life. At the forum,Pfizer Officially ReleasesA new DTP strategy centered on "service standardization, integration of in-hospital and out-of-hospital services, and information unification."By establishing a unified quantitative standard to evaluate and dynamically rank the partnered DTP pharmacies, and linking resources and incentive policies to the ranking results, we aim to fundamentally reduce service level fluctuations caused by regional differences, ensuring that every patient can enjoy a standardized level of service.

Yuanxin Technology, as a long-term ecosystem partner of Pfizer China and a pioneer in the field of off-hospital prescription drug services, has been vigorously building in recent years."Standardization, Digitalization, Refinement"Professional Pharmacy Grading Management System.Around"Horizontal commerce + vertical research" dual dimensions, precisely matching the full lifecycle needs of drugs from R&D and market launch to clinical use., and provide ecological partners with a "progressive and functionally complementary" service matrix. —— Basic PharmacyEnsure compliance with pharmaceutical supply and provide basic medication guidance;Professional PharmacyRelying on the Yuanxin Patient Management Platform to achieve full coverage of record-keeping, follow-up, electronic medication history, and automatic generation of DOT;Research PharmacyThis links to a specialized disease database, supporting RWS and IIT, and building a solid data foundation for clinical research.

Yuanxin TechnologyChairman of the Board andCEO He Tao emphasized in the forum: "The graded management of professional pharmacies cannot be separated from the systematic development of pharmacists' capabilities. Yuanxin Technology not only continuously enhances pharmacists' professional knowledge and service abilities through a training system, but also leverages artificial intelligence technology to expand the reach of standardized services, promoting the evolution of the pharmacist role towards greater professionalism, standardization, and accessibility."

In terms of hospital-pharmacy collaboration, Yuanxin Technology's concept far exceeds the traditional."Hospital Prescribes, Pharmacy Dispenses" Model.But rather, it plays a role among industry partners, clinical departments, and patients."Connector" and "Amplifier" Roles,Break down information and service barriers,Form from"Information Transfer" to "Full-Process Care"The Cross-Departmental Collaborative Patient Management System.

This system was proposed by Pfizer."The 'Hospital-Store Linkage' strategy is highly aligned." Cao Zhi, head of Pfizer China's Commerce and Retail Division, illustrated in the forum: "For instance, when cancer patients are discharged, their treatment plans and rehabilitation needs are transferred to DTP pharmacies through a standardized process, ensuring that patients receive continuous and comprehensive care across different scenarios."

Yuanxin Technology's Hospital-Store Collaboration PracticeExactlyIs a testament to this philosophy.LandingDeepen: Through”Source Partner Intelligent Agent Group"Technology empowerment inStandardized Patient Management PathwayApplyAI Tools Expand the Scope and Depth of Patient Management Services, achieving seamless connection throughout the entire process from in-hospital diagnosis and treatment to out-of-hospital medication management and rehabilitation follow-up, ensuring that patients receive professional, continuous, and personalized pharmaceutical services and health management at every stage.

During this year's CIIE, Yuanxin Technology and Pfizer have entered a new phase of strategic cooperation, marking a further deepening of their collaboration in the commercialization of innovative drugs throughout their entire life cycle. He Tao stated: "We will continue to be patient-centered, clinically value-oriented, and driven by data and technology. Together with global leading pharmaceutical companies like Pfizer, we will jointly promote China's DTP industry towards a higher quality and more sustainable development path."

In the future, Yuanxin Technology hopes to work with pharmaceutical companies, medical institutions, industry associations, and other ecosystem partners to jointly promote the standardized construction of DTP pharmacies, enhance pharmacists' capabilities, and connect digital platforms. This effort aims to build a new ecosystem for pharmaceutical services that is open, collaborative, and value-sharing. By continuously optimizing the dual-driven model of "tiered management + hospital-pharmacy collaboration," Yuanxin Technology is committed to bridging the "last mile" of innovative drug commercialization, providing Chinese patients with safer, more efficient, and more accessible pharmaceutical and healthcare services, thereby supporting the steady realization of the "Healthy China" strategy.

THE  END 

Selected Highlights